ID: h-0ca9a295f6
Hypothesis

Rutin enhances chaperone and autophagic clearance of misfolded tau

The compound acts primarily through HSP70 and lysosomal proteostasis pathways, reducing seeded aggregate burden in intact neurons.
🧬 SQSTM1🩺 neurodegeneration🎯 Composite 60%💱 $0.55▼8.5%proposed
EvidencePending (0%)📖 4 cit🗣 1 debates 4 support 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.63 (15%) Evidence 0.49 (15%) Novelty 0.58 (12%) Feasibility 0.73 (12%) Impact 0.59 (12%) Druggability 0.50 (10%) Safety 0.68 (8%) Competition 0.55 (6%) Data Avail. 0.64 (5%) Reproducible 0.60 (5%) KG Connect 0.50 (8%) 0.599 composite

🧪 Overview

The compound acts primarily through HSP70 and lysosomal proteostasis pathways, reducing seeded aggregate burden in intact neurons.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Ubiquitinated Cargo<br/>Misfolded Proteins/Organelles"]
    B["SQSTM1/p62 UBA Domain<br/>Ubiquitin Chain Recognition"]
    C["SQSTM1 Oligomerization<br/>LIR Motif Exposure"]
    D["LC3-II Interaction<br/>Autophagosome Docking"]
    E["Cargo Sequestration<br/>Autophagosome Engulfment"]
    F["NRF2 Release<br/>KEAP1-p62 Competition"]
    G["Lysosomal Degradation<br/>Proteostasis Restored"]
    H["SQSTM1 Aggregates<br/>ALS/FTD Pathology"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> G
    B --> F
    F -.->|"antioxidant"| G
    C --> H
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#1b5e20,stroke:#81c784,color:#81c784
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix4 supports1 contradicts
Supports
Targeting inflammation, autophagy, and apoptosis by troxerutin attenuates neurodegeneration.
Int Immunopharmacol2022PMID:33146846medium
Supports
p62 filaments capture and present ubiquitinated cargos for autophagy.
Cell2022PMID:35807447high
Supports
The upstream pathway of mTOR-mediated autophagy in liver diseases.
Cells2022PMID:35718184medium
Supports
Autophagy regulation by polyphenolic compounds as a therapeutic strategy.
Brain Res2024PMID:40687556medium
Contradicts
Without pathway-ablation data this model is too nonspecific to prioritize first.
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SQSTM1

No curated PDB or AlphaFold mapping for SQSTM1 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for SQSTM1 from GTEx v10.

Cerebellar Hemisphere74.9 Cerebellum67.7median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SQSTM1 →

No DepMap CRISPR Chronos data found for SQSTM1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.6%
Volatility
Low
0.0021
Events (7d)
3
Price History
▼8.5%

💾 Resource Usage

LLM Tokens
1,743
$0.0052
Total Cost
$0.0052

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF we apply rutin (10 µM) to iPSC‑derived cortical neurons in which SQSTM1 (p62) has been knocked out by CRISPR for 7 days, THEN the rutin‑induced reduction in tau aggregate burden observed in SQSTM1 Loss of rutin‑mediated tau aggregate reduction (<10% change) in SQSTM1 knockout neurons, while wild‑type neurons show ≥30% reduction— no observation —pending0.55
IF we treat primary cortical neurons seeded with human P301S tau fibrils with rutin (10 µM) once daily for 7 days, THEN we will observe a statistically significant reduction of at least 30% in deterge≥30% decrease in detergent‑insoluble tau as quantified by Western blot or ELISA— no observation —pending0.65
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we treat primary cortical neurons seeded with human P301S tau fibrils with rutin (10 µM) once daily for 7 days, THEN we will observe a statistically significant reduction of at least 30% in detergent‑insoluble tau levels compared to vehicle‑treated neurons within 2 weeks after treatment initiatio
Predicted outcome: ≥30% decrease in detergent‑insoluble tau as quantified by Western blot or ELISA
Falsification: No statistically significant change in detergent‑insoluble tau (i.e., <10% change) after rutin treatment, indicating the compound does not reduce seeded tau aggregates under these conditions
pendingconf 55%
IF we apply rutin (10 µM) to iPSC‑derived cortical neurons in which SQSTM1 (p62) has been knocked out by CRISPR for 7 days, THEN the rutin‑induced reduction in tau aggregate burden observed in SQSTM1 wild‑type neurons will be abolished (i.e., <10% change), indicating SQSTM1 is required for rutin’s e
Predicted outcome: Loss of rutin‑mediated tau aggregate reduction (<10% change) in SQSTM1 knockout neurons, while wild‑type neurons show ≥30% reduction
Falsification: Rutin still reduces tau aggregates by ≥30% in SQSTM1 knockout neurons, disproving the requirement of SQSTM1 for rutin’s action
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.